A Phase 1/ Phase 2 Study of TTHX1114(NM141)
Public ClinicalTrials.gov record NCT04520321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/ Phase 2 Study Evaluating the Safety and Efficacy of the Investigational New Drug TTHX1114(NM141) on the Regeneration of Corneal Endothelial Cells in Patients With Corneal Endothelial Dystrophies Following Intracameral Delivery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Prospective, multicenter, randomized, masked, vehicle-controlled, dose-escalation study
Study identification
- NCT ID
- NCT04520321
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 22 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 19, 2020 (Actual)
- Primary completion
- Apr 23, 2021 (Actual)
- Completion
- May 18, 2021 (Actual)
- Last update posted
- Oct 30, 2023
2020 – 2021
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North Bay Eye Associates, Inc. | Petaluma | California | 94954 | — |
| Levenson Eye Associates, Inc | Jacksonville | Florida | 32204 | — |
| Chicago Corneal Consultants | Hoffman Estates | Illinois | 60169 | — |
| Price Vision Group | Indianapolis | Indiana | 46260 | — |
| Tauber Eye Center | Kansas City | Missouri | 64111 | — |
| Vance Thompson Vision - Omaha | Omaha | Nebraska | 68137 | — |
| Alterman, Modi and Wolter | Poughkeepsie | New York | 12603 | — |
| Vance Thompson Vision - Sioux Falls | Sioux Falls | South Dakota | 57108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04520321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 30, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04520321 live on ClinicalTrials.gov.